Cargando…
Enhanced toxicity to chemoradiation in a patient with Anti-Jo-1-antisynthetase syndrome
Appropriate counseling of patients with autoimmune connective tissue disorders (ACTDs) is often challenging for radiation oncologists, especially regarding anticipated side-effects of radiation treatment. These patients can have highly variable and unpredictable sequelae from radiation therapy, and...
Autores principales: | Valle, Luca, Katz, James, Duffy, Austin, Hueman, Matthew, Wang, Hao-Wei, Hughes, Marybeth, Sissung, Tristan, Figg, William, Citrin, Deborah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461731/ https://www.ncbi.nlm.nih.gov/pubmed/36101738 http://dx.doi.org/10.1259/bjrcr.20210188 |
Ejemplares similares
-
Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome
por: Marie, Isabelle, et al.
Publicado: (2013) -
Anti-Jo-1 autoantibodies: biomarkers of severity and evolution of the disease in antisynthetase syndrome
por: Arcani, Robin, et al.
Publicado: (2023) -
40. Challenges in the management of a patient with tophaceous gout and anti-Jo 1 positive antisynthetase syndrome
por: Stathopoulou, Eleni, et al.
Publicado: (2017) -
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study
por: Cavagna, Lorenzo, et al.
Publicado: (2015) -
Single Nucleotide Polymorphism in the IL17A Gene Is Associated with Interstitial Lung Disease Positive to Anti-Jo1 Antisynthetase Autoantibodies
por: Ponce-Gallegos, Marco Antonio, et al.
Publicado: (2021)